-
Register
- Non-member - $50
- Member - $25
According to the CDC, more than 37 million American have diabetes and approximately 90-95% of those individuals have type 2 diabetes (DM2). Although DM2 is not a primary hospice diagnosis, managing medications and symptoms related to DM2 is necessary for holistic hospice patient care. The impact of DM2 as a chronic condition can contribute to the patient’s hospice prognosis of six months or less. This presentation will provide an overview of the care of individuals with DM2 in hospice supported by patient case discussion to review common medication classes, goals of therapy, and shared decision-making for deprescribing.
Presented by: Bridget McCrate Protus, PharmD, MLIS, BCGP, CDP Director of Drug Information Optum Hospice Pharmacy Services 614-964-3282 bridget.protus@optum.com